Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Ameritas Advisory Services LLC

Ameritas Advisory Services LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 24.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,628 shares of the medical equipment provider’s stock after buying an additional 324 shares during the period. Ameritas Advisory Services LLC’s holdings in Intuitive Surgical were worth $850,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA purchased a new stake in shares of Intuitive Surgical in the third quarter valued at about $558,807,000. International Assets Investment Management LLC increased its stake in shares of Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. FMR LLC raised its stake in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB raised its position in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares during the period. Finally, State Street Corp lifted its stake in shares of Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 1,012 shares of the firm’s stock in a transaction dated Friday, October 25th. The stock was sold at an average price of $514.00, for a total transaction of $520,168.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,830,084. This trade represents a 15.53 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 43,509 shares of company stock worth $22,602,212. 0.80% of the stock is owned by insiders.

Intuitive Surgical Trading Up 1.9 %

Shares of Intuitive Surgical stock opened at $604.12 on Wednesday. Intuitive Surgical, Inc. has a 52 week low of $362.14 and a 52 week high of $606.27. The stock has a market cap of $215.18 billion, a PE ratio of 97.13, a price-to-earnings-growth ratio of 5.04 and a beta of 1.39. The company’s 50-day moving average price is $541.80 and its two-hundred day moving average price is $500.76.

Analyst Ratings Changes

ISRG has been the topic of several recent research reports. Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. Truist Financial raised their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. Piper Sandler reissued an “overweight” rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Citigroup increased their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Finally, JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.